Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Hasegawa, Daisuke  [Clear All Filters]
2023
Imai C, Sato A, Hiwatari M, Shimomura Y, Hori T, Suenobu S, Imamura T, Hara J, Hasegawa D, Takahashi H, et al. Outcomes following induction failure in Japanese children with acute lymphoblastic leukemia. Int J Hematol. 2023.
Raghuram N, Nakashima K, Rahman SAb, Antoniou E, Skajaa T, Merli P, Verma A, Rabin KR, Aftandilian C, Kotecha RSury, et al. Survival Outcomes of Children with Relapsed or Refractory Myeloid Leukemia Associated with Down syndrome. Blood Adv. 2023.
2022
Tomizawa D, Tsujimoto S-I, Tanaka S, Matsubayashi J, Aoki T, Iwamoto S, Hasegawa D, Nagai K, Nakashima K, Kawaguchi K, et al. A phase III clinical trial evaluating efficacy and safety of minimal residual disease-based risk stratification for children with acute myeloid leukemia, incorporating a randomized study of gemtuzumab ozogamicin in combination with post-induction chemothe. Jpn J Clin Oncol. 2022.
2021
Yamamoto S, Kato M, Watanabe K, Ishimaru S, Hasegawa D, Noguchi M, Hama A, Sato M, Koike T, Iwasaki F, et al. Prognostic value of the revised International Prognostic Scoring System five-group cytogenetic abnormality classification for the outcome prediction of hematopoietic stem cell transplantation in pediatric myelodysplastic syndrome. Bone Marrow Transplant. 2021.
2019
Ishimaru S, Okamoto Y, Imai C, Sakaguchi H, Taki T, Hasegawa D, Cho Y, Kakuda H, Sano H, Manabe A, et al. Nationwide Survey of Pediatric Hypodiploid Acute Lymphoblastic Leukemia in Japan. Pediatr Int. 2019.